Journal title MISSION
Author/s Felice Nava, Alfio Lucchini, Marco Riglietta, Liborio Cammarata, Paola Fasciani, Giovanni Tavanti, Paola Trotta, Lucia Trevisi
Publishing Year 2020 Issue 2020/54
Language Italian Pages 0 P. File size 0 KB
DOI 10.3280/mis54-2020oa10582
DOI is like a bar code for intellectual property: to have more infomation
click here
FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.
The epidemiological data suggests that people who use drugs (PWUDs) are the most important “reservoir” for the spread of HCV infection. For this reason PWUDs should be included in all HCV elimination plan as priority target for treatment.We performed an observational study in 5 Italian Drug Abuse Services (SerDs) with the main aims to determine: 1) the prevalence of HCV infection in PWUDs; 2) the most important barriers to HCV treatment.Of the about 4,000 drug users included in the study only about the 36% was tested and of them the 20% were anti HCV positive; only about the 60% of the HCV RNA positive patients were treated.The study showed several important barriers to the screening, especially when cannot used rapid tests and/or if test is not proposed periodically, and to the linkage to care, in particular when the HCV treatment cannot be given inside the SerDs.The study has also revealed as the harm reduction measures as suggested by WHO are not offered to all PWUDs. In conclusion the study suggests how inside the SerDs the barriers for HCV treatment that can be overcome with a simpler model of treatment as represented by the point of care.
Keywords: HCV; PWUDs; Point of care; DAAs; Harm reduction
Felice Nava, Alfio Lucchini, Marco Riglietta, Liborio Cammarata, Paola Fasciani, Giovanni Tavanti, Paola Trotta, Lucia Trevisi, Barriers for HCV treatment in Italian Drug Abuse Service: Data from a multicentric observational study (SCUDO Project) in "MISSION" 54/2020, pp , DOI: 10.3280/mis54-2020oa10582